HomeCompareBNOX vs VICI

BNOX vs VICI: Dividend Comparison 2026

BNOX yields 790.20% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BNOX wins by $2499877.61M in total portfolio value
10 years
BNOX
BNOX
● Live price
790.20%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2499878.58M
Annual income
$2,001,595,404,407.55
Full BNOX calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — BNOX vs VICI

📍 BNOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNOXVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNOX + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNOX pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNOX
Annual income on $10K today (after 15% tax)
$67,167.13/yr
After 10yr DRIP, annual income (after tax)
$1,701,356,093,746.42/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, BNOX beats the other by $1,701,355,577,476.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNOX + VICI for your $10,000?

BNOX: 50%VICI: 50%
100% VICI50/50100% BNOX
Portfolio after 10yr
$1249939.77M
Annual income
$1,000,798,005,891.84/yr
Blended yield
80.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

BNOX
Analyst Ratings
4
Buy
Consensus: Buy
Price Target
$6.00
+2270.6% upside vs current
Range: $6.00 — $6.00
Altman Z
-82.3
Piotroski
5/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNOX buys
0
VICI buys
0
No recent congressional trades found for BNOX or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNOXVICI
Forward yield790.20%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$2499878.58M$966.2K
Annual income after 10y$2,001,595,404,407.55$607,376.13
Total dividends collected$2460392.87M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$6.00$31.60

Year-by-year: BNOX vs VICI ($10,000, DRIP)

YearBNOX PortfolioBNOX Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$89,720$79,020.15$11,361$941.49+$78.4KBNOX
2$758,589$662,588.76$13,320$1,481.32+$745.3KBNOX
3$6,047,418$5,235,727.31$16,284$2,405.01+$6.03MBNOX
4$45,478,990$39,008,252.73$21,040$4,071.78+$45.46MBNOX
5$322,828,490$274,165,970.92$29,209$7,285.49+$322.80MBNOX
6$2,164,251,074$1,818,824,589.26$44,443$14,006.51+$2164.21MBNOX
7$13,711,496,364$11,395,747,714.83$75,822$29,512.55+$13711.42MBNOX
8$82,145,270,460$67,473,969,350.51$148,733$69,726.75+$82145.12MBNOX
9$465,685,208,688$377,789,769,296.29$344,394$189,413.75+$465684.86MBNOX
10$2,499,878,577,704$2,001,595,404,407.55$966,234$607,376.13+$2499877.61MBNOX

BNOX vs VICI: Complete Analysis 2026

BNOXStock

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.

Full BNOX Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this BNOX vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNOX vs SCHDBNOX vs JEPIBNOX vs OBNOX vs KOBNOX vs MAINBNOX vs NNNBNOX vs EPRTBNOX vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.